uniQure (QURE) Revenue & Revenue Breakdown
uniQure Revenue Highlights
Latest Revenue (Y)
$27.12M
Latest Revenue (Q)
$2.29M
Main Segment (Y)
Collaboration revenues
uniQure Revenue by Period
uniQure Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $27.12M | 71.17% |
| 2023-12-31 | $15.84M | -85.12% |
| 2022-12-31 | $106.48M | -79.68% |
| 2021-12-31 | $524.00M | 1296.82% |
| 2020-12-31 | $37.51M | 415.23% |
| 2019-12-31 | $7.28M | -35.48% |
| 2018-12-31 | $11.28M | -13.91% |
| 2017-12-31 | $13.11M | -47.78% |
| 2016-12-31 | $25.10M | 143.57% |
| 2015-12-31 | $10.30M | 80.87% |
| 2014-12-31 | $5.70M | 40.19% |
| 2013-12-31 | $4.06M | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | - |
uniQure generated $27.12M in revenue during NA 2024, up 71.17% compared to the previous quarter, and up 372.46% compared to the same period a year ago.
uniQure Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $2.29M | -79.44% |
| 2024-06-30 | $11.13M | 31.13% |
| 2024-03-31 | $8.48M | 26.85% |
| 2023-12-31 | $6.69M | 375.41% |
| 2023-09-30 | $1.41M | -41.91% |
| 2023-06-30 | $2.42M | -54.52% |
| 2023-03-31 | $5.33M | -94.82% |
| 2022-12-31 | $102.75M | 6990.75% |
| 2022-09-30 | $1.45M | 191.55% |
| 2022-06-30 | $497.00K | -72.27% |
| 2022-03-31 | $1.79M | -96.89% |
| 2021-12-31 | $57.69M | 2800.50% |
| 2021-09-30 | $1.99M | -99.57% |
| 2021-06-30 | $463.87M | 102073.57% |
| 2021-03-31 | $454.00K | -98.67% |
| 2020-12-31 | $34.09M | 1805.31% |
| 2020-09-30 | $1.79M | 16.55% |
| 2020-06-30 | $1.53M | 1375.96% |
| 2020-03-31 | $104.00K | -96.04% |
| 2019-12-31 | $2.63M | 150.96% |
| 2019-09-30 | $1.05M | -57.72% |
| 2019-06-30 | $2.47M | 117.78% |
| 2019-03-31 | $1.14M | -29.35% |
| 2018-12-31 | $1.61M | -48.92% |
| 2018-09-30 | $3.15M | 3.21% |
| 2018-06-30 | $3.05M | -12.31% |
| 2018-03-31 | $3.48M | 34.60% |
| 2017-12-31 | $2.58M | 14.34% |
| 2017-09-30 | $2.26M | -54.27% |
| 2017-06-30 | $4.94M | 48.81% |
| 2017-03-31 | $3.32M | -63.28% |
| 2016-12-31 | $9.05M | 24.69% |
| 2016-09-30 | $7.25M | 65.48% |
| 2016-06-30 | $4.38M | -0.87% |
| 2016-03-31 | $4.42M | 19.61% |
| 2015-12-31 | $3.70M | 4.31% |
| 2015-09-30 | $3.54M | 95.67% |
| 2015-06-30 | $1.81M | 51.10% |
| 2015-03-31 | $1.20M | -26.00% |
| 2014-12-31 | $1.62M | 27.54% |
| 2014-09-30 | $1.27M | -10.65% |
| 2014-06-30 | $1.42M | -11.65% |
| 2014-03-31 | $1.61M | 24.13% |
| 2013-12-31 | $1.30M | -25.70% |
| 2013-09-30 | $1.74M | 76.93% |
| 2013-06-30 | $986.16K | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | - |
uniQure generated $2.29M in revenue during Q3 2024, up -79.44% compared to the previous quarter, and up 94.43% compared to the same period a year ago.
uniQure Revenue Breakdown
uniQure Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| License revenues | $10.13M | $2.76M | $100.00M | $517.40M | - |
| Collaboration revenues | $10.87M | $2.25M | $4.77M | $6.60M | - |
| License revenues from related party | - | - | - | - | - |
| Collaborative Revenue From Related Party | - | - | - | - | $136.00K |
| License | - | - | - | - | $4.35M |
| License Revenue From Related Party | - | - | - | - | $32.97M |
| Collaborative Revenue | - | - | - | - | $59.00K |
Latest
uniQure's latest annual revenue breakdown by segment (product or service), as of Dec 24: Collaboration revenues (51.76%), and License revenues (48.24%).
Quarterly Revenue by Product
| Product/Service | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| License revenues | $4.95M | $2.11M | $1.87M | $1.20M | $1.97M | $793.00K | $55.00M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Collaboration revenues | $246.00K | $200.00K | $7.13M | $3.29M | $1.54M | $319.00K | $388.00K | $1.03M | $1.45M | $497.00K | $1.79M | $2.69M | - | - | - | - | - | - | - | - |
| Collaborative Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.99M | $1.47M | $454.00K | - | - | - | - | - |
| License | - | - | - | - | - | - | - | - | - | - | - | - | - | $462.40M | - | - | - | - | - | - |
| Collaborative Revenue From Related Party | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $61.00K | $13.00K | $5.00K | $57.00K | $1.14M |
| License Revenue From Related Party | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.61M | $1.78M | $1.53M | $47.00K | $1.48M |
Latest
uniQure's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: License revenues (95.27%), and Collaboration revenues (4.73%).
uniQure Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals | $423.24M | $112.21M |
| DAWN | Day One Biopharmaceuticals | $131.16M | $20.07M |
| RYTM | Rhythm Pharmaceuticals | $130.13M | $29.08M |
| AMLX | Amylyx Pharmaceuticals | $87.37M | $416.00K |
| RGNX | REGENXBIO | $83.33M | $24.20M |
| STRO | Sutro Biopharma | $62.04M | $25.71M |
| PHAT | Phathom Pharmaceuticals | $55.25M | $16.35M |
| MRUS | Merus | $36.13M | $11.77M |
| MGTX | MeiraGTx | $33.28M | $10.91M |
| QURE | uniQure | $27.12M | $2.29M |
| SNDX | Syndax Pharmaceuticals | $23.68M | $12.50M |
| RNA | Avidity Biosciences | $10.90M | $2.04M |
| XFOR | X4 Pharmaceuticals | $2.56M | $560.00K |
| GPCR | Structure Therapeutics | - | - |
| SLDB | Solid Biosciences | - | - |
| PTGX | Protagonist Therapeutics | - | $4.67M |
| PCVX | Vaxcyte | - | - |
| RCKT | Rocket Pharmaceuticals | - | - |
| REPL | Replimune Group | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| LRMR | Larimar Therapeutics | - | - |